Brandon Folkes

Stock Analyst at HC Wainwright & Co.

(0)
# 4608
Out of 5,356 analysts
75
Total ratings
33.33%
Success rate
-15.58%
Average return
35 Stocks
Name Action PT Current % Upside Ratings Updated
MIST Milestone Pharmaceut...
Assumes: Buy
5
1.73 189.02% 2 Jun 5, 2025
CRDL Cardiol Therapeutics
Initiates Coverage On: Buy
9
1.38 552.17% 1 Jun 2, 2025
PYPD PolyPid
Assumes: Buy
11
3.16 248.1% 2 Jun 2, 2025
TRVI Trevi Therapeutics
Initiates Coverage On: Buy
21
6.77 210.19% 2 May 28, 2025
RMTI Rockwell Medical
Initiates Coverage On: Buy
5
0.97 415.46% 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
3.53 239.94% 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
3.9 130.77% 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
3.27 175.23% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
0.66 1112.12% 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
6.08 163.16% 6 Sep 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
13
13.2 -1.52% 1 Aug 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
4.3 86.05% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
2 250% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
0.53 1786.79% 2 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
455
6.36 7054.09% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
59
28.78 105% 4 Sep 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8
n/a n/a 4 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
180
108.81 65.43% 2 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 15
n/a n/a 2 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
30 22
0.6 3566.67% 3 Dec 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
5
n/a n/a 1 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
6
n/a n/a 1 Jun 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
7.57 18.89% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
28 32
31.05 3.06% 3 Jan 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
40
n/a n/a 1 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
22000
1.91 1151732.46% 1 Aug 31, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30 22
29.47 -25.35% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
3125
n/a n/a 1 Aug 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
38 53
n/a n/a 4 Aug 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
78 40
59.83 -33.14% 3 May 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
405 315
n/a n/a 3 Mar 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 46
n/a n/a 6 Mar 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 42
n/a n/a 2 Sep 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 50
16.16 209.41% 1 Jul 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
7 4
n/a n/a 2 Mar 13, 2018